companyName


89bio, Inc. Website Screenshot

http://www.89bio.com

89bio, Inc. Company Intro

89bio is a clinical-stage biopharmaceutical company focused on rapidly advancing our lead product candidate, BIO89-100, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH). BIO89-100 is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It may be a differentiated FGF21 therapy, and we believe it has the potential to become a mainstay of therapy for NASH given its ability to address the key liver pathologies (steatosis and fibrosis) and underlying metabolic dysregulation in patients with NASH. We are also expanding the breadth of indications for BIO89-100 with an initial focus on severe hypertriglyceridemia (SHTG).

Industry

Healthcare

89bio, Inc. Headquaters

142 Sansome Street
San Francisco,94104
United States


89bio, Inc. Share price

14 Sep 2022 09:10 GMT

$7.51

2.51 (50.2 %)


89bio, Inc. Market cap

$141.975 M


WMC RANKING

2022

89bio, Inc. # 479

Biotechnology

Latest 89bio, Inc. News

News 03 Dec 2022

After This Week's 0.72% Gain In 89bio Inc. (NASDAQ: ETNB ...

89bio Inc. (NASDAQ:ETNB)'s traded shares stood at 0.42 million during the last session. At the close of trading, the stock's price was $8.41,...

News 01 Dec 2022

In What Direction Will 89bio Inc.'s (NASDAQ:ETNB) Stock ...

89bio Inc. (NASDAQ: ETNB) closed the day trading at $8.00 up 2.43% from the previous closing price of $7.81. In other words, the price has increased by...

News 01 Dec 2022

In What Direction Will 89bio Inc.'s (NASDAQ:ETNB) Stock ...

89bio Inc. (NASDAQ: ETNB) closed the day trading at $8.00 up 2.43% from the previous closing price of $7.81. In other words, the price has increased by...


WMC Market Score


WMC Market to Revenue Score


89bio, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
89bio, Inc. USD $0 $53,392 $-53,737 $1,420M 479
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total 89bio, Inc. Social Followers vs Top 4 Industry Competitors



89bio, Inc. Post vs Top 4 Industry Competitors




89bio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



89bio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



89bio, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
89bio, Inc. 0 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries